Join
Live feed
·
PRReleasevia Quantisnow
Mesoblast Limited logo

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

ByQuantisnow·Wall Street's wire, on your screen.
MESO· Mesoblast Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MESO (Mesoblast Limited) and more on Quantisnow.